Search

Search Constraints

You searched for: Author/Creator Swisher, Elizabeth M.

Search Results

1. An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions. (May 2020)

2. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Issue 2 (18th July 2012)

3. CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study. Issue 1 (1st January 2023)

4. Characterization of Precursor Lesions in the Endometrium and Fallopian Tube Epithelium of Early-Stage Uterine Serous Carcinoma. (January 2015)

5. Characterization of Precursor Lesions in the Endometrium and Fallopian Tube Epithelium of Early-Stage Uterine Serous Carcinoma. (January 2015)

6. Characterization of Precursor Lesions in the Endometrium and Fallopian Tube Epithelium of Early-Stage Uterine Serous Carcinoma. (January 2015)

8. Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study. Issue 34 (1st December 2022)

9. Impact of Homologous Recombination Status and Responses With Veliparib Combined With First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study. Issue 5 (May 2022)

10. Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety. (21st September 2021)